Maternal and fetal outcomes in pregnancies complicated by Marfan syndrome

Heart. 2019 Nov;105(22):1725-1731. doi: 10.1136/heartjnl-2019-314817. Epub 2019 May 25.

Abstract

Objectives: Information to guide counselling and management for pregnancy in women with Marfan syndrome (MFS) is limited. We therefore conducted a UK multicentre study.

Methods: Retrospective observational study of women with MFS delivering between January 1998 and March 2018 in 12 UK centres reporting data on maternal and neonatal outcomes.

Results: In total, there were 258 pregnancies in 151 women with MFS (19 women had prior aortic root replacements), including 226 pregnancies ≥24 weeks (two sets of twins), 20 miscarriages and 12 pregnancy terminations. Excluding miscarriages and terminations, there were 221 live births in 139 women. Only 50% of women received preconception counselling. There were no deaths, but five women experienced aortic dissection (1.9%; one type A and four type B-one had a type B dissection at 12 weeks and subsequent termination of pregnancy). Five women required cardiac surgery postpartum. No predictors for aortic dissection could be identified. The babies of the 131 (65.8%) women taking beta-blockers were on average 316 g lighter (p<0.001). Caesarean section rates were high (50%), particularly in women with dilated aortic roots. In 55 women, echocardiographic aortic imaging was available prepregnancy and postpregnancy; there was a small but significant average increase in AoR size of 0.84 mm (Median follow-up 2.3 months) CONCLUSION: There were no maternal deaths, and the aortic dissection rate was 1.9% (mainly type B). There with no identifiable factors associated with aortic dissection in our cohort. Preconception counselling rates were low and need improvement. Aortic size measurements increased marginally following pregnancy.

Keywords: aortic dissection or intramural hematoma; marfan and associated disorders; pregnancy.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aortic Aneurysm / diagnostic imaging
  • Aortic Aneurysm / epidemiology*
  • Aortic Aneurysm / therapy
  • Aortic Dissection / diagnostic imaging
  • Aortic Dissection / epidemiology*
  • Aortic Dissection / therapy
  • Birth Weight
  • Cardiac Surgical Procedures
  • Cesarean Section
  • Counseling
  • Female
  • Humans
  • Infant, Newborn
  • Live Birth
  • Marfan Syndrome / diagnosis
  • Marfan Syndrome / epidemiology*
  • Marfan Syndrome / therapy
  • Preconception Care
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / diagnostic imaging
  • Pregnancy Complications, Cardiovascular / epidemiology*
  • Pregnancy Complications, Cardiovascular / therapy
  • Premature Birth / epidemiology
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Stillbirth / epidemiology
  • Treatment Outcome
  • United Kingdom / epidemiology
  • Young Adult

Substances

  • Adrenergic beta-Antagonists